Mirum Pharmaceuticals Inc (MIRM)
25.72
+0.61
(+2.43%)
USD |
NASDAQ |
May 01, 16:00
25.72
0.00 (0.00%)
After-Hours: 20:00
Mirum Pharmaceuticals Profit Margin (Quarterly): -51.27% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -51.27% |
| September 30, 2023 | -49.42% |
| June 30, 2023 | -197.5% |
| March 31, 2023 | -95.35% |
| December 31, 2022 | -130.5% |
| September 30, 2022 | -190.1% |
| Date | Value |
|---|---|
| June 30, 2022 | -154.0% |
| March 31, 2022 | -283.9% |
| December 31, 2021 | |
| September 30, 2021 | -942.2% |
| June 30, 2021 | -399.0% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-942.2%
Minimum
Sep 2021
-49.42%
Maximum
Sep 2023
-249.3%
Average
-172.1%
Median
Profit Margin (Quarterly) Benchmarks
| Gilead Sciences Inc | -62.37% |
| Vanda Pharmaceuticals Inc | -5.30% |
| Sarepta Therapeutics Inc | 11.51% |
| Puma Biotechnology Inc | 17.00% |
| Reneo Pharmaceuticals Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -92.90% |
| Return on Assets | -33.66% |
| Return on Invested Capital | -45.45% |
| Gross Profit Margin (Quarterly) | 64.03% |
| Operating Margin (Quarterly) | -46.85% |
| Return on Net Operating Assets | -85.06% |